生物类似药上市后风险管理的现状及启示
赵明, 吕俊玲, 齐文渊, 刘岳, 李可欣, 薛薇
Present situation and enlightenment of biosimilar post-marketing risk management
ZHAO Ming, LV Jun-ling, QI Wen-yuan, LIU Yue, LI Ke-xin, XUE Wei
临床药物治疗杂志
.
2020, (5): 7
-11
.
DOI: 10.3969/j.issn.1672-3384.2020.05.002
